Toxic pathological effect of mitomycin-c on male reproductive organs in rat

  • Hala Abbas Naji Department of pathology and poultery diseases/College of Veterinary Medicine/ University of AL-Qadisiyah
  • Khalil Gazar Chelab Department of pathology and poultery diseases/College of Veterinary Medicine/ University of AL-Qadisiyah
  • Atiaf Ghanim Rhyaf Department of pathology and poultry diseases, College of Veterinary Medicine/ University of AL-Qadisiyah

Abstract

The aim of present study was detected the effect of Mitomycin-c on the histological structure on male reproductive organ. In this study used (24) healthy adult male rats were divided into three groups, each group includes (8) animals: the 1st toxic group was injected (6.5mg/kg) of Mitomycin-c subcutaneous (s/c) once daily, the 2ed therapeutic or low dose group was injected (3.25 mg/kg) of Mitomycin-c subcutaneous (s/c) once daily, while the 3rd control group was injected physiological normal saline (0.9% NaCl2). The experimental period was (10) weeks. Animal, which were treated with Mitomycin-c along the period of experiment showed, sever pathological changes, particularly in testes and epididymis.

References

1-Carter SK, Livingston RB. Drugs available to treat cancer. In Carter, S.K.:Principles of cancer treatment. McGraw, Hill.; New York. (1981).
2-Theilin GH. Chemotherapy. In Theilen GH, Madewell BR. Veterinary Cancer Medicine. 2 nd , Ed., Lea and Febiger, Philadelphia, (1987);pp 1315- 1318.
3-Boulton AJM, Carpenter JR, Clark B, Dascombe MJ, De akin JFM, Dive C, Duxbury AJ, Foster RW. Antiparasitic Chemotherap y. In Basic pharmacology. 4 th Ed., Oxford Auckland Boston and ohannesburg Melbourne, New Delhi, (1996);pp 269-274.
4-Danshiitsoodol N, de Pinho CA, Matoba Y, Kumagai T, Sugiyama M. "The mitomycin C (MMC)-binding protein from MMC-producing microorganisms protects from the lethal effect of bleomycin: crystallographic analysis to elucidate the binding mode of the antibiotic to the protein". J Molec Biol (2006);360 (2): 398–408.
5-Tomasz Maria. "Mitomycin C: small, fast and deadly (but very selective)." Chemistry and Biology (1995);2 (9): 575–579.
6-Renault J, Baron M, Mailliet P et al. Heterocyclic quinones 2. Quinoxaline-5,6-(and 5-8)-diones - Potential antitumoral agents. Eur. J. Med. Chem. (1981);16, 6, 545–550.
7-Hata TY Sano, R Sugawara, A Matsumae, K Kanamori, T Shima , T Hoshi. Mitomycin anew antibiotic from streptomyces. j antibiotic. (1956);9,141-146.
8-Wakaki SH Marumo, K Tomioka, G Shimizu, E Kato, H Kamado, S Kuda, Y Fujimoto. Isolation of new fractions of antitumor mitomycins .Antibiotic chemother. (1958);8,228-240.
9-Luna LG. Manual of Histologic staining methods of the armed forces. Institute of Pathology. 3 rd ,Ed., McGraw-Hill Book Company, N.Y., Toronto, London, Sydney (1968);pp.12-31.
10-Chemwatch Material Safety Data Sheet.( 2011). TCH 32647 C293LP Version No:6.1.1.1P:14 -19. www.biochem.uci.edu/.../MSDS/Mitomycin%20C%20 .
11-Van VJ , deRooij DG,Wensing CJ, Bootsma AL.Protection of spermatogenesis against cytotoxic effects of two chemotherapeutic drugs by temporary testicular blood flow interruption in the arm . Sep.Oct, (1993);25(5):251-6.
12-Xiao Y, Tates AD. Increased frequencies of micronuclei in early spermatids of rats following exposure of young primary spermatocytes to acrylamide. Sep.(1994);309(2):245-53.
13-Soichi N, Chisato M. Detection of mitomycin c induced testicular toxicity by micronucleus in mice. Vol.(2), No.(2), (2003); 69-73.del:10.1046/j.1445-5781. 2003.00023.x.
14-Nakagawa S,Nakamura N, Fujioka M , Moric. Spermatogenic cell apoptosis induced by mitomycin c in the mouse testis Toxicol Appl pharmacol .Dec. (1997);147(2):204-13.
15-Sjoblom T, Parvinen M, Landetie J. Stage specific DNA synthesis of rat spermatogenesis an indicator of genotoxic effect of vinblastine ,mitomycin-c &ionizing radiation on rat spermatogenia & spermatocytes .Mutat Res .Oct.(1995);331(2):181-90.
16-Drews Jurgen. Drug discovery :Ahitorical perspective )Science (2000);287:1960-1964.
17-Ritter JM, Lewis LD, Mant TGK. Chemotherapy. A textbook of clinical pharmacology. 4th Ed., Hodder Headline Group, London;(1999);pp:555-558.
Published
2018-12-30